Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

Clinical Trial Title

Step-Up yellow zone inhaled corticosteroids to prevent exacerbations

Clinical Trial Protocol Description:

The objective of this study is to determine whether, in children receiving low-dose ICS, quintupling the dose of inhaled corticosteroids in the “yellow zone” based upon a symptom-based action plan reduces the rate of severe asthma exacerbations treated with oral corticosteroids.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have asthma.
  • Be between the ages of 5-11 years old.

This is a partial list of inclusion criteria.

Study Details

Clinical Trial Investigator

James Moy, MD

Contact Information

Samantha Zitzer

(312) 563-4178